RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Tsuyoshi Fujita to Cell Line, Tumor

This is a "connection" page, showing publications Tsuyoshi Fujita has written about Cell Line, Tumor.
Connection Strength

0.058
  1. Yoshimoto T, Fujita T, Kajiya M, Matsuda S, Ouhara K, Shiba H, Kurihara H. Involvement of smad2 and Erk/Akt cascade in TGF-?1-induced apoptosis in human gingival epithelial cells. Cytokine. 2015 Sep; 75(1):165-73.
    View in: PubMed
    Score: 0.017
  2. Tsunematsu T, Kudo Y, Iizuka S, Ogawa I, Fujita T, Kurihara H, Abiko Y, Takata T. RUNX3 has an oncogenic role in head and neck cancer. PLoS One. 2009 Jun 12; 4(6):e5892.
    View in: PubMed
    Score: 0.012
  3. Igarashi Y, Trujillo ME, Mart?nez-Molina E, Yanase S, Miyanaga S, Obata T, Sakurai H, Saiki I, Fujita T, Furumai T. Antitumor anthraquinones from an endophytic actinomycete Micromonospora lupini sp. nov. Bioorg Med Chem Lett. 2007 Jul 01; 17(13):3702-5.
    View in: PubMed
    Score: 0.010
  4. Miyanaga S, Obata T, Onaka H, Fujita T, Saito N, Sakurai H, Saiki I, Furumai T, Igarashi Y. Absolute configuration and antitumor activity of myxochelin A produced by Nonomuraea pusilla TP-A0861. J Antibiot (Tokyo). 2006 Nov; 59(11):698-703.
    View in: PubMed
    Score: 0.010
  5. Igarashi Y, Miura SS, Fujita T, Furumai T. Pterocidin, a cytotoxic compound from the endophytic Streptomyces hygroscopicus. J Antibiot (Tokyo). 2006 Mar; 59(3):193-5.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support